automated-news
Ascendis Pharma A/S (NASDAQ:ASND) Issues Quarterly Earnings Results, Misses Expectations By $0.58 EPS
Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report) posted its quarterly earnings data on Wednesday. The biotechnology company reported ($0.64) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.58), Zacks reports. The company had revenue of $290.38 million for the